Literature DB >> 21667302

Dropout from outpatient mental health care: results from the Israel National Health Survey.

Yaacov Lerner1, Daphna Levinson.   

Abstract

OBJECTIVES: To examine the dropout rates from outpatient mental health treatment in the general medical and mental health sectors and to identify the predictors of dropout.
METHOD: The study population was extracted from the Israel National Health Survey. The analysis was related to 12-month service utilization for mental health reasons.
RESULTS: The total dropout rate from mental health treatment was 24%, but differed between sectors. The dropout rate from general medical care was 32, and 22% from mental health care. In the general medical care sector, 30% ended treatment within two visits, while only 10% did so in the mental health-care sector. Chronic health condition, but not severity of psychiatric disorder, predicted dropout in the mental health sector. DISCUSSION: The higher rate of early dropout in general medical care may be related to the brevity of general medical visits and/or the inexperience of primary care physicians, which limits the opportunity to develop patient-physician rapport. Providers of services will have to promote education programs for GPs and allocate proper time to psychiatric patients. LIMITATION: The sample, although based on a national representative cohort, was small and limited the number of independent variables that could be examined.

Entities:  

Mesh:

Year:  2011        PMID: 21667302     DOI: 10.1007/s00127-011-0402-8

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  26 in total

1.  Twelve-month service utilization rates for mental health reasons: data from the Israel National Health Survey.

Authors:  Daphna Levinson; Yaacov Lerner; Nelly Zilber; Alexander Grinshpoon; Itzhak Levav
Journal:  Isr J Psychiatry Relat Sci       Date:  2007       Impact factor: 0.481

2.  Dropping out of mental health treatment: patterns and predictors among epidemiological survey respondents in the United States and Ontario.

Authors:  Mark J Edlund; Philip S Wang; Patricia A Berglund; Stephen J Katz; Elizabeth Lin; Ronald C Kessler
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

3.  Mental health treatment dropout and its correlates in a general population sample.

Authors:  JianLi Wang
Journal:  Med Care       Date:  2007-03       Impact factor: 2.983

4.  Perceived barriers to mental health service utilization in the United States, Ontario, and the Netherlands.

Authors:  Jitender Sareen; Amit Jagdeo; Brian J Cox; Ian Clara; Margreet ten Have; Shay-Lee Belik; Ron de Graaf; Murray B Stein
Journal:  Psychiatr Serv       Date:  2007-03       Impact factor: 3.084

5.  Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders.

Authors:  Ramin Mojtabai; Mark Olfson; David Mechanic
Journal:  Arch Gen Psychiatry       Date:  2002-01

6.  Mental disorders and mental health care in Canada and Australia: comparative epidemiological findings.

Authors:  Raymond Tempier; Graham N Meadows; Helen-Maria Vasiliadis; Karen E Mosier; Alain Lesage; Anna Stiller; Annette Graham; Marje Lepnurm
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-14       Impact factor: 4.328

7.  Attitudes of Israeli primary care physicians towards mental health care.

Authors:  Margalit Goldfracht; Chani Shalit; Ofra Peled; Diane Levin
Journal:  Isr J Psychiatry Relat Sci       Date:  2007       Impact factor: 0.481

8.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

Authors:  Koen Demyttenaere; Ronny Bruffaerts; Jose Posada-Villa; Isabelle Gasquet; Viviane Kovess; Jean Pierre Lepine; Matthias C Angermeyer; Sebastian Bernert; Giovanni de Girolamo; Pierluigi Morosini; Gabriella Polidori; Takehiko Kikkawa; Norito Kawakami; Yutaka Ono; Tadashi Takeshima; Hidenori Uda; Elie G Karam; John A Fayyad; Aimee N Karam; Zeina N Mneimneh; Maria Elena Medina-Mora; Guilherme Borges; Carmen Lara; Ron de Graaf; Johan Ormel; Oye Gureje; Yucun Shen; Yueqin Huang; Mingyuan Zhang; Jordi Alonso; Josep Maria Haro; Gemma Vilagut; Evelyn J Bromet; Semyon Gluzman; Charles Webb; Ronald C Kessler; Kathleen R Merikangas; James C Anthony; Michael R Von Korff; Philip S Wang; Traolach S Brugha; Sergio Aguilar-Gaxiola; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Alan M Zaslavsky; T Bedirhan Ustun; Somnath Chatterji
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

9.  Prevalence of mood and anxiety disorders in the community: results from the Israel National Health Survey.

Authors:  Daphna Levinson; Nelly Zilber; Yaacov Lerner; Alexander Grinshpoon; Itzhak Levav
Journal:  Isr J Psychiatry Relat Sci       Date:  2007       Impact factor: 0.481

10.  Dropout from outpatient mental health care in the United States.

Authors:  Mark Olfson; Ramin Mojtabai; Nancy A Sampson; Irving Hwang; Benjamin Druss; Philip S Wang; Kenneth B Wells; Harold Alan Pincus; Ronald C Kessler
Journal:  Psychiatr Serv       Date:  2009-07       Impact factor: 4.157

View more
  3 in total

Review 1.  [Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].

Authors:  A Chevance; D Gourion; N Hoertel; P-M Llorca; P Thomas; R Bocher; M-R Moro; V Laprévote; A Benyamina; P Fossati; M Masson; E Leaune; M Leboyer; R Gaillard
Journal:  Encephale       Date:  2020-04-02       Impact factor: 1.291

2.  Process evaluation of a district mental healthcare plan in Nepal: a mixed-methods case study.

Authors:  Nagendra P Luitel; Erica Breuer; Anup Adhikari; Brandon A Kohrt; Crick Lund; Ivan H Komproe; Mark J D Jordans
Journal:  BJPsych Open       Date:  2020-07-28

Review 3.  Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review.

Authors:  A Chevance; D Gourion; N Hoertel; P-M Llorca; P Thomas; R Bocher; M-R Moro; V Laprévote; A Benyamina; P Fossati; M Masson; E Leaune; M Leboyer; R Gaillard
Journal:  Encephale       Date:  2020-04-22       Impact factor: 1.291

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.